首页> 外文期刊>Data in Brief >Data on plug-based large-bore arteriotomy vascular closure device related access complications
【24h】

Data on plug-based large-bore arteriotomy vascular closure device related access complications

机译:基于插头的大型孔动脉术血管闭合装置的数据相关的接入并发症

获取原文
           

摘要

This article provides supplementary tables and figures to the research article: Frequency, Impact and Predictors of Access Complications with Plug-Based Large-Bore Arteriotomy Closure - A patient level meta-analysis . The data provide insight in the type and management of access complications related to the plug-based MANTA vascular closure device (VCD) for large-bore catheter-based cardiovascular interventions. Since MANTA is mostly used in transcatheter aortic valve replacement (TAVR) procedures, this article also contains a sub-group analysis on TAVR procedures using contemporary valve-platforms. Further, data describing MANTA hemostasis times and mortality causes are included. For this dataset, individual patient data were derived from a European and a North American device approval study (the Conformite Européene [CE] mark study and the investigational device exemption SAFE-MANTA study ,) in addition to a post-approval registry (the MARVEL registry ) covering a total of 891 patients who were enrolled between 2015 and 2019 across 28 investigational sites. Eligibility criteria were most stringent in the SAFE MANTA study (38% of patients) whereas the MARVEL registry applied liberal and only relative exclusion criteria (56% of patients). A total of 78 Roll-in cases (i.e. first or second time operator use of the MANTA VCD) who were excluded from analysis in SAFE MANTA were included in the present to evaluate a potential learning curve effect. Therefore, this dataset reflects the largest study population undergoing arteriotomy closure with the MANTA VCD by operators at various levels of experience, which can be valuable to further build on research regarding percutaneous large-bore arteriotomy management.
机译:本文提供的补充表格和图形的研究文章:频次,影响和访问的预测并发症与基于插件大口径的动脉切口闭合 - 患者级荟萃分析。这些数据提供了在相关的基于栓塞的血管敏达闭合装置(VCD)为基于导管大口径心血管干预通路并发症的类型和管理的洞察力。由于敏达在导管主动脉瓣置换(TAVR)程序大多采用,本文还包含有关使用当代阀的平台TAVR程序亚组分析。此外,在描述敏达止血时间和死亡率的原因数据也包括在内。对于这个数据集,个别病人数据来自欧洲和北美的设备审批研究(在符合欧洲标准[CE]标记的学习和研究性器械豁免SAFE-敏达研究)除了批准后注册表(奇迹派生注册表)共占地谁是在28个研究性网站登记的2015年至2019年间891个例。合格的标准是在SAFE敏达研究最严格的(38%的患者),而MARVEL注册表施加自由和只有相对的排除标准(56%的患者)。总共78无障碍的情况下(即,第一或第二时间操作者使用敏达VCD的)谁在SAFE敏达从分析中排除了包含在本来评价潜在学习曲线效果的。因此,该数据集反映了从曼塔VCD各级的经验,这可能是研究关于经皮大口径的动脉切口管理进一步建立有价值最大的研究人群正在接受动脉切开封闭运营商。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号